2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Cholangitis: new trials by email Literature Review of Cholangitis trials Research Report on Cholangitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibiotics to Decrease Post ERCP Cholangitis Ceftriaxone, Levofloxacin - Cholangitis | Phase 4 | Unknown | University of Southern California | 200 | 2017-03-29 | 2023-03-06 |
| Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients Vancomycin, Placebo - Primary Sclerosing Cholangitis | Phase 4 | Unknown | Tehran University of Medical Sciences | 30 | 2015-09-01 | 2015-11-16 |
Bile Duct Diseases (2) · Biliary Tract Diseases (2) · Digestive System Diseases (2)
Ceftriaxone (1) · Levofloxacin (1) · Vancomycin (1)
Tehran University of Medical Sciences (1) · University of Southern California (1)
Iran (1) · United States (1)
James Buxbaum (1) · Mohammad Kazem NouriTaromlou, M.D. (1) · Mohsen Nasiri Toosi, Professor (1) · Naser Ebrahimi Daryani, Professor (1) · Sanam Javidanbardan, M.D. (1) · Shahab Rahimpour, fellowship (1) · Zahra Azizi, M.D. (1)
PMID 15557948, PMID 17509029, PMID 17696583, PMID 18061594, PMID 18462108, PMID 19238021, PMID 19286178, PMID 20927758, PMID 21692712, PMID 21835401, PMID 2209498, PMID 23307001, PMID 25442089, PMID 8779455